LAURUSLABS - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.6
| Stock Code | LAURUSLABS | Market Cap | 59,436 Cr. | Current Price | 1,101 ₹ | High / Low | 1,145 ₹ |
| Stock P/E | 80.3 | Book Value | 97.3 ₹ | Dividend Yield | 0.11 % | ROCE | 15.9 % |
| ROE | 15.1 % | Face Value | 2.00 ₹ | DMA 50 | 1,060 ₹ | DMA 200 | 952 ₹ |
| Chg in FII Hold | -0.70 % | Chg in DII Hold | 1.54 % | PAT Qtr | 192 Cr. | PAT Prev Qtr | 175 Cr. |
| RSI | 54.4 | MACD | 20.5 | Volume | 24,48,088 | Avg Vol 1Wk | 19,52,953 |
| Low price | 572 ₹ | High price | 1,145 ₹ | PEG Ratio | -90.2 | Debt to equity | 0.40 |
| 52w Index | 92.3 % | Qtr Profit Var | -23.9 % | EPS | 13.7 ₹ | Industry PE | 30.1 |
📊 Analysis: LAURUSLABS shows moderate intraday potential. Current price ₹1,101 is near resistance levels, with RSI at 54.4 indicating neutral momentum. Volume (24.5 lakh) is above average, suggesting active participation, but stretched valuations (P/E 80.3 vs industry 30.1) and negative profit variation (-23.9%) limit upside confidence.
💹 Optimal Buy Zone: ₹1,085 – ₹1,095 (close to DMA 50 support at ₹1,060).
🎯 Profit-Taking Levels: ₹1,120 – ₹1,130 (short-term resistance) and ₹1,140 – ₹1,145 (session high).
🛑 Stop-Loss Zone: ₹1,075 – ₹1,080 (below intraday support).
⏳ Intraday Exit Guidance: If already holding, exit if RSI falls below 50 with declining volume (<20 lakh), or if price fails to sustain above ₹1,095. Momentum exit advisable if price stagnates below ₹1,120 despite strong volume.
Positive
- ROCE (15.9%) and ROE (15.1%) remain healthy.
- PAT improved to ₹192 Cr. from ₹175 Cr. sequentially.
- Strong trading activity with volume above 1-week average.
Limitation
- High P/E (80.3) compared to industry average (30.1).
- Negative PEG ratio (-90.2) indicates poor valuation alignment with growth.
- Quarterly profit variation (-23.9%) raises caution.
Company Negative News
- FII holding declined (-0.70%), showing reduced foreign investor confidence.
- Profitability volatility despite revenue growth.
Company Positive News
- DII holding increased (+1.54%), reflecting domestic institutional support.
- Improved ROCE and ROE metrics compared to prior quarters.
Industry
- Pharma sector trading at PE ~30.1, significantly lower than LAURUSLABS valuation.
- Sector outlook stable with moderate growth expectations.
Conclusion
⚖️ LAURUSLABS offers tactical intraday trading potential with a rating of 3.6. Best suited for momentum trades between ₹1,085–₹1,130. Traders should maintain tight stop-losses and exit if momentum weakens below ₹1,095. Long-term valuations remain stretched, so intraday trades should be short-term tactical rather than positional.
Would you like me to extend this into a multi-session swing trade report (2–5 days) with adjusted entry/exit zones and sector overlays for benchmarking?